Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US.
Parthan, Anju 1,5; Kruse, Morgan 1; Yurgin, Nicole 2; Huang, Joice 2,4; Viswanathan, Hema N. 2; Taylor, Douglas 1,3
[Article] Applied Health Economics & Health Policy. 11(5):485-497, October 2013.

(Format: HTML, PDF)